804 studies found for:    Attention Deficit-Hyperactivity Disorder
Show Display Options
Rank Status Study
21 Completed PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Volunteer;   Attention Deficit Hyperactivity Disorder
Intervention:
22 Completed
Has Results
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy;   Behavioral: Behavior Therapy
23 Completed
Has Results
Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate 20 mg long-acting capsules
24 Completed
Has Results
An Efficacy Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: OROS Methylphenidate HCl
25 Completed
Has Results
A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: LY2216684;   Drug: Methylphenidate;   Drug: Placebo (tablet);   Drug: Placebo (capsule)
26 Completed
Has Results
A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Drug: Osmotic Release Oral System Methylphenidate Hydrochloride (OROS-MPH);   Other: No intervention
27 Completed A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: methylphenidate hydrochloride extended-release tablets
28 Recruiting Omega-3 Fatty Acid Supplementation to Stimulants in Children With Attention Deficit Hyperactivity Disorder and Deficient Emotional Self-Regulation
Conditions: Attention Deficit Hyperactivity Disorder;   Deficient Emotional Self-Regulation
Interventions: Dietary Supplement: Omega-3 Fatty Acid;   Drug: Stimulant Medication
29 Completed A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
30 Completed A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
31 Unknown  Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention:
32 Recruiting Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention: Other: Behavioral assessment and NAT EEG tests
33 Recruiting Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
34 Recruiting Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Behavioral: Academic and Organization skills;   Behavioral: Parent Training;   Behavioral: Social Skills Training;   Drug: Long-acting stimulant
35 Active, not recruiting Plasma Orexin A and mRNA Expression Levels of Pre-pro-orexin Gene in Attention-Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Intervention:
36 Active, not recruiting Electroencephalogram and Attention Deficit Hyperactivity Disorder Study
Conditions: Attention Deficit Hyperactivity Disorder;   Healthy Controls
Intervention: Device: Electroencephalogram (EEG)
37 Not yet recruiting Exercise Effects in Children With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit/Hyperactivity Disorder
Intervention: Other: Physical activity
38 Completed Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate extended-release; Atomoxetine
39 Completed
Has Results
A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: atomoxetine hydrochloride;   Drug: Placebo
40 Completed CONCERTA (OROS Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: CONCERTA (OROS methylphenidate hydrochloride)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years